Cloud PR Wire

Category: Vehement Media Network

  • Cambria Gold Mines Announces Premier Assay Results and Spin Out Plan for a US Copper Project

    Cambria Gold Mines announced the first results from its ongoing infill drilling at the Premier Gold Project (PGP), located in northwestern British Columbia. Cambria Gold Mines began trading on February 13, 2026. Cambria’s short and long-term business objectives involve the synchronised development of two lead assets in BC’s Golden Triangle.

    Canada, 27th Apr 2026– Global Stocks News – Sponsored content disseminated on behalf of Cambria Gold Mines. On April 21, 2026, Cambria Gold Mines (TSXV: CAMB; OTCID: AOTVF) announced the first results from its ongoing infill drilling at the Premier Gold Project (PGP), located in northwestern British Columbia. Highlight intercept: 22 meters @ 17.95 grams per tonne (g/t) gold, including 552.0 g/t gold over 0.5 meters.

    Cambria Gold Mines began trading on February 13, 2026. Cambria’s short and long-term business objectives involve the synchronised development of two lead assets in BC’s Golden Triangle.

    The Premier Gold Project has paved road access, grid-connected hydroelectric power, and proximity to a deep-water port. Multiple deposits include Premier, Silver Coin, Big Missouri, Dilworth, and Martha Ellen.

    Red Mountain is a high-grade underground gold deposit, located approximately 15 kilometres northeast of Stewart, BC, within Nisga’a Nation Treaty Lands, in BC’s Golden Triangle.

    “We intend that the Premier Gold Project will serve as an infrastructure and processing hub, while Red Mountain is prioritized as the initial source of high-confidence mill feed,” Robert McLeod, President and CEO of Cambria Gold Mines, told Guy Bennett, the CEO of Global Stocks News (GSN).

    “We have our first drill results from the 2026 season at the Premier Gold Project,” stated McLeod in an April 21, 2026, News Explained YouTube Short. “With our first drill hole, we absolutely nailed it with about 18 grams per tonne over 22 meters. That’s very close to true widths. It’s from the 602 zone, which is on the western side of the famous Premier Gold Mine.”

    “We released the first five drill holes of our 27,000-meter ongoing infill drilling program at the Premier Gold Project,” added McLeod. “We currently have two drills that are underground on the opposite side of the ore body, called the Prew Zone.”

    “This drilling at the 602 Zone is delineating high-grade mineralization, which could be accessed with additional development from the recently constructed underground workings at the historic Premier Mine,” confirmed McLeod in the April 21 press release. “Two underground drills are currently delineating the Prew Zone at Premier; our objective is to establish the strong continuity similar to the nine primary shoots that were historically mined at the deposit.”

    Results from the first five diamond drill holes completed, totalling 1,815 meters, were reported from the “602 Zone” of the Premier-Northern Lights deposit. Drilling is focused on infill of Indicated and Inferred Resources at the Premier deposits to provide the necessary drill spacing for development planning.

    The Cambria geological team believes that the lack of infill drilling during development was a critical factor in the difficulties encountered during the mining operations that led to a shutdown of operations in 2024.

    Above: Plan Map showing 602 Zone surface drilling at the Premier – Northern Lights deposit 

    The scientific and technical information within this news release was reviewed and approved by Blaine Smit, P.Geo. Vice President Exploration for Cambria Gold Mines Inc. Mr. Smit is a “Qualified Person” as defined under National Instrument 43-101 – Standards of Disclosure for Mineral Projects and is not independent of the Company. To verify the information related to this news release, Mr. Smit visited the 2026 drilling operations to review and discuss logging, sampling, and shipping procedures with responsible site staff, and reviewed and discussed assay and QA/QC results with responsible company personnel.

    On April 22, 2026 Cambria announced the completion of additional claim staking at the Mt. Margaret copper-gold porphyry deposit near Randle, Washington.

    The new staking consists of approximately seven square kilometres of unpatented lode claims surrounding the Cambria’s patented federal claims. The patented claims are held in partnership with the United States Federal Government Bureau of Land Management. 

    Cambria Gold has been advancing discussions with various US Federal Government Departments regarding the future direction for the deposit. These discussions have led Cambria to initiate a plan to “spin out” the copper asset into a new US entity.

    “There’s a historic resource that was completed prior to National Instrument, 43-101, and shouldn’t be relied upon,” confirmed McLeod in an April 22, 2026 News Explained YouTube Short.  “It’s 577 million tonnes at 0.36 % copper and 0.24g/t Au. This was drilled in the 1970s. The historic resource was established in 1977. The only other work was done in 2010 when Ascot Resources completed 10 drill holes, and almost all of them ended in mineralization.” [See Footnote 1 for full disclosure details on the historic resource]

    “Mount Margaret is potentially one of the most significant copper resources in the United States,” added McLeod in the YouTube video. “It is our intention at Cambria to spin this company out into a new US-domiciled entity. We expect that to happen within the next couple of months. Stay tuned for more news on how we’re going to advance Mount Margaret.”

    Note: the scientific and technical information within this release was reviewed and approved by Blaine Smit, P.Geo. Vice President Exploration for Cambria Gold Mines, and is therefore not independent. Mr. Smit is a “Qualified Person” as defined under NI 43-101 and visited the Mt. Margaret project in March of 2026 to review 2010 drill core, property geology, and monumented drill collars.  Mr. Smit was not involved with the 2010 drill program by Ascot Resources Ltd. and is relying on the publicly available disclosures and internally available assay and QA/QC files, along with physical review of drill core, to verify the results of the 2010 drilling. 

    Contact: guy.bennett@globalstocksnews.com 

    Disclaimer: Cambria Gold Mines paid Global Stocks News (GSN) $1,750 for the research, writing and dissemination of this content. 

    Footnote:

    1. The historical resource estimate was completed by Duval Corporation for the Mt. Margaret deposit, with 577Mt grading 0.36% Cu, 0.24 g/t Au, 0.011% Mo, and 1.58 g/t Ag (Taylor, 1980 & Derkley et al, 1990).1,2  This historic estimation work predates the implementation of National Instrument 43-101 – Standards of Disclosure for Mineral Projects (“NI-43-101”) guidelines and was not classified based on currently accepted reserve and resource classifications as set forth by the Canadian Institute of Mining and Metallurgy, August 20, 2000 (CIM Guidelines) or the United States Securities and Exchange Commission’s Regulation Subpart 1300 of Regulation S-K (“S-K 1300”).  Cambria cautions it is not treating the historic Duval work as a current mineral resource estimate, and there has been insufficient work completed by a Qualified Person to do so at any point in the project’s history.  Furthermore, uncertainty regarding cut off grade, metal prices, modelling methodology, or other parameters and assumptions used in the Duval work could impact the reliability of the historic estimation.  Cambria still considers the Duval work relevant given the number of supporting historical drillholes, many of which were confirmed by subsequent Ascot drilling in 2010.  Further work including additional infill drilling, geological modelling, and assay certificate and collar validation by a Qualified Person pursuant to NI 43-101 would be required to produce a NI-43-101 or an S-K 1300 compliant resource.  There are no guarantees that this additional work would confirm the historical resource estimate defined by Duval.

    Media Contact

    Organization: Global Stocks News

    Contact Person: guy.bennett@globalstocksnews.com

    Website: https://www.globalstocksnews.com

    Email: Send Email

    Country:Canada

    Release id:44407

    The post Cambria Gold Mines Announces Premier Assay Results and Spin Out Plan for a US Copper Project appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

    file

  • CMS (867.HK/8A8.SG) Signed An Exclusive Commercialization and Supply Agreement for Marketed Originator Intravenous Iron Products Monofer® and Cosmofer®

    SHENZHEN, CHINA – China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that, the Group through its wholly-owned subsidiary entered into an exclusive commercialization and supply agreement (the “Agreement”) with Pharmacosmos A/S for Iron Isomaltoside Injection (“Monofer®”) and Iron Dextran Injection (“Cosmofer®”) recently. In accordance with the Agreement, the Group has obtained an exclusive right to commercialize the products in the People’s Republic of China (for the purpose of this Agreement, excluding the Hong Kong Special Administrative Region, the Macau Special Administrative Region and Taiwan region). Pharmacosmos A/S will continue to manufacture and supply the products. The cooperation term shall be fifteen years from the effective date stipulated in the Agreement, which may be extended upon mutual agreement between the parties prior to expiry.

     

    The two intravenous iron therapies under this cooperation are both originator products that have been approved for marketing in China and included in the China’s National Reimbursement Drug List (NRDL). Among them, Monofer® is an exclusive drug and the first third-generation intravenous iron therapy approved for marketing in China. It features an innovative and more stable matrix-like nanostructure and provides a superior safety profile[1]. Its single-dose full iron replenishment significantly reduces the number of infusions, enables faster improvement in hemoglobin levels and enhances clinical convenience. Another product, Cosmofer®, is currently the only intravenous iron therapy included in Category A of the NRDL and also the only one included in the National Essential Medicines List (NEML). With many years of accumulated clinical use, its efficacy and safety have been supported by accumulated clinical experience and published data.

     

    The above two products will form a comprehensive intravenous iron product portfolio covering all channels and treatment scenarios, which can support meeting the clinical needs of different levels of healthcare institutions and different types of iron deficiency anemia (IDA) patients, providing more diversified, safe and effective treatment options for patients. Patients with iron deficiency (ID) and IDA are widely distributed across multiple clinical departments, including gastroenterology, cardiology, nephrology, obstetrics and gynecology, and orthopedics, which are all key specialty areas of the Group. The addition of the two products will generate efficient synergies with the Group’s existing marketed products in expert resources and academic promotion network, further strengthening the Group’s overall competitiveness in the field of anemia treatment, and is expected to have a positive impact on the Group’s performance.

     

    More information about Monofer®

    Monofer® was approved on 30 January 2021 for the treatment of iron deficiency in patients where oral iron preparations are ineffective, cannot be used, or where there is a clinical need for rapid iron supplementation. In 2023, Monofer® was included in the NRDL as a Category B reimbursable drug. Monofer® consists of nanoparticles with a stable, matrix-like structure composed of interchanging layers of iron atoms and short, linear isomaltose carbohydrates. This structure enables controlled iron release with low levels of labile iron, contributing to a favourable safety profile, including a low risk of hypersensitivity reactions and hypophosphatemia. Monofer® can be administered as a high-dose infusion of 1,000 mg or more in a single visit, whereas older therapies such as iron sucrose typically require repeated administrations of 100 to 200 mg. This enables full iron repletion in one treatment, reducing the need for multiple infusions, lowering the burden on patients and healthcare systems, and increasing infusion capacity. At the same time, the low risk of hypophosphatemia helps avoid complications such as fractures and supports recovery from fatigue, a key symptom of iron deficiency anaemia.

     

    More information about Cosmofer®

    Cosmofer® is a second-generation low-molecular-weight iron dextran injection. It was approved for marketing in Mainland China in 2003 and is indicated for patients with iron deficiency who cannot take oral iron preparations (such as those who are intolerant to oral iron or have unsatisfactory therapeutic outcomes). Cosmofer® also allows single-dose high-dose iron repletion. With many years of accumulated clinical use, its efficacy and safety have been supported by accumulated clinical experience and published data. Its dual status as a Category A NRDL-listed product and NEML supports its core role in iron supplementation in primary healthcare settings.

     

    About Iron Deficiency and Iron Deficiency Anemia

    ID and IDA are global health issues that commonly affect children, premenopausal women (particularly pregnant women) and the elderly. These conditions may impair the function of multiple organ systems, leading to a series of health problems such as growth retardation, behavioral disorders, cognitive impairment, reduced physical capacity, and peri-natal and peri-operative complications. They also significantly affect the prognosis of chronic diseases such as gastrointestinal diseases, chronic kidney disease, heart failure and tumors[2]. More than 1 billion people live with iron deficiency anaemia[3], making it one of the leading contributors to the global burden of disease[4]. Data from the Fourth National Nutrition Survey in China indicate that the prevalence of IDA among Chinese residents is 20.1%[5]. However, both patients and healthcare professionals have insufficient awareness of the disease. Less than 20% of patients with mild anemia receive diagnosis and treatment, while only about 50% of patients with severe anemia receive appropriate diagnosis and treatment[2]. This indicates significant underdiagnosis and undertreatment of ID/IDA. Iron supplementation is the standard treatment for ID/IDA and includes oral iron therapy and intravenous iron therapy. Intravenous iron therapy is an important option for patients who cannot tolerate oral iron, have inadequate response to oral therapy, require rapid iron repletion, or prefer full iron supplementation within one to two administrations[1,2,6]. However, due to insufficient awareness of IDA, patient adherence issues, hospitalization constraints, infusion convenience, and safety concerns regarding intravenous iron therapies, the clinical use of intravenous iron in China remains relatively conservative. A Chinese real-world study shows that the average total dose of iron sucrose used in IDA patients was approximately 511 mg, which was significantly lower than the target dose of 1,000 mg[2]. There is therefore a significant clinical need for intravenous iron therapies that offer high safety, strong demonstrated efficacy and single-dose full iron repletion. Monofer® and Cosmofer® together establish a comprehensive intravenous iron product portfolio covering multiple treatment scenarios, providing tiered treatment options for patients with iron deficiency anemia.

     

    About Pharmacosmos A/S

    Pharmacosmos A/S is a global leader in carbohydrate chemistry and innovative treatments for iron deficiency and iron deficiency anemia. Leveraging its deep expertise in carbohydrate chemistry and cell cycle biology, the company is committed to developing innovative therapies to address unmet patient needs, with a particular focus on iron metabolism and hematology-related diseases. Pharmacosmos A/S was founded in 1965 and is headquartered in Denmark, and employs more than 700 specialists from the United Kingdom, Ireland, the Nordic countries, Germany, the United States, Canada and China. With excellent product quality and strong clinical value, its core iron therapy products have been approved and widely used in multiple countries and regions worldwide, establishing strong technological capabilities and a solid market reputation.

     

    About CMS

    CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.

     

    CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.

     

    CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardiovascular-kidney-metabolic/gastroenterology/ophthalmology/skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.

     

    Reference:

    1. Chinese Pharmacological Society Professional Committee of Drug‑induced Diseases, Guangdong Pharmaceutical Association. Expert consensus of clinical application and pharmaceutical care for intravenous iron agents (2024) [J]. Adverse Drug Reactions Journal, 2025, 27(3): 129-141. DOI: 10.3760/cma.j.cn114015⁃20240929⁃00070
    2. Liao Minjing, Zhang Liansheng. Standardized diagnosis and treatment of iron deficiency and iron‑deficiency anemia [J]. Chinese Journal of Internal Medicine, 2023, 62(6): 722-727. DOI: 10.3760/cma.j.cn112138-20230210-00074.
    3. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME); 2020. Available from http://ghdx.healthdata.org/gbd-results-tool.
    4. Pasricha SR, Tye-Din J, Muckenthaler MU, Swinkels DW. Iron deficiency. Lancet. 2021 Jan 16;397(10270):233-248.
    5. Li Lijuan, Zhang Liansheng. Considerations on the standardized diagnosis and treatment of iron‑deficiency anemia [J]. National Medical Journal of China, 2021, 101(40): 3266-3270. DOI: 10.3760/cma.j.cn112137-20210609-01319.
    6. Red Blood Cell Disease (Anemia) Group, Chinese Society of Hematology, Chinese Medical Association. Multidisciplinary expert consensus on the diagnosis, treatment and prevention of iron deficiency and iron deficiency anemia (2022 edition) [J]. National Medical Journal of China, 2022, 102(41): 3246-3256. DOI: 10.3760/cma. j.cn112137-20220621-01361.

     

    CMS Disclaimer and Forward-Looking Statements

    This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.

    This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.

     

    Media Contact

    Brand: China Medical System Holdings Ltd.

    Contact: CMS Investor Relations

    Email: ir@cms.net.cn

    Website: https://web.cms.net.cn/en/home/

  • German-Korean Biotech Startup Koralo Announces Clinical Research Update and Expansion Strategy

    German-Korean biotech startup Koralo has announced an update regarding its ongoing research and development activities, alongside its broader operational expansion plans.

    The company stated that it recently conducted a clinical study in the United States as part of its continued efforts to develop postbiotic-based ingredients using its proprietary co-fermentation technology. The research forms part of Koralo’s wider initiative to explore applications of fermentation-derived compounds across multiple sectors.

    Koralo is currently operating a manufacturing base in Jeonju, South Korea, where it is leveraging local fermentation infrastructure to support its production and development processes. The facility is expected to play a role in the company’s planned expansion into international markets.

    According to the company, its co-fermentation platform is being used to develop two product categories—one intended for human food applications and another for aquafeed. Both product lines are derived from a shared production approach, allowing for consistency across applications.

    The company noted that its ingredients are designed for integration into a range of formats, including beverages, dairy products, baked goods, dietary supplements, and feed solutions. These developments are part of Koralo’s broader focus on ingredient innovation within the food and feed industries.

    Koralo indicated that it is currently targeting the United States and South Korea for its food-related initiatives, while also exploring opportunities in Europe and Southeast Asia for aquafeed applications.

    The company stated that it will continue to focus on research and development of fermentation-based ingredients, with ongoing efforts directed toward expanding its presence in global markets.

    Media Contact

    Organization: Koralo GmbH (Koralo Co., Ltd.)

    Contact Person: Sina Albanese (CEO)

    Website: http://www.koralo-foods.com/

    Email: Send Email

    Country:Korea South

    Release id:44299

    The post German-Korean Biotech Startup Koralo Announces Clinical Research Update and Expansion Strategy appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

    file

  • Genoscience Wins 2026 Global Award for High-Purity Research Peptides

    Sarasota, Florida, United States, 27th Apr 2026 – Genoscience, a premier U.S. supplier of high-purity research peptides, announced it has received the 2026 Global Recognition Award. The company was honored for redefining institutional laboratory procurement through a secure supply chain built on domestic logistics, cGMP-compliant sourcing, and 99% analytical transparency.

    Founded by Kristelle Dammarell, Genoscience entered a scientific supply market flooded with unverified importers. Historically, scientists sourcing Research Peptides in the U.S. frequently encountered reagents of uncertain origin, jeopardizing the reproducibility of complex in-vitro assays. Genoscience solved this structural failure by building a specialized procurement model. As a dedicated scientific supplier, the company ensures its entire inventory is manufactured under strict Current Good Manufacturing Practice (cGMP) regulations, guaranteeing uncompromising batch-to-batch consistency for longitudinal studies.

    Today, when principal investigators are buying research peptides online, analytical verification is paramount. Operating on the principle of verifiable data, Genoscience mandates independent High-Performance Liquid Chromatography (HPLC) and mass spectrometry testing for every batch. This publicly available reporting ensures laboratories receive only High-Purity Research Peptides. Furthermore, Genoscience’s Sarasota-based fulfillment eliminates the risks of international customs delays, utilizing secure, climate-stable logistics to ensure lyophilized compounds arrive with their peptide bonds and structural conformations fully intact.

    Beyond secure procurement, the company supports the scientific community through the Genoscience Hub. This dedicated educational platform equips researchers with detailed guides, stringent handling protocols, and advanced literature to prevent thermal degradation at the bench.

    “The fidelity of your research data is entirely dependent on the quality of your reagents,” said Kristelle Dammarell, Founder of Genoscience. “We designed our domestic logistics network, our automated subscription model, and the Genoscience Hub around what principal investigators actually need: >99% verified purity, cGMP-sourced consistency, and uninterrupted supply continuity for their Research Peptides.”

    The 2026 Global Recognition Award evaluated Genoscience’s operational excellence across six categories, utilizing the Rasch model to verify performance. The award corroborates the company’s commitment to equipping bench scientists with the precise, institutional-grade molecular tools required to execute highly reproducible structural biology and cellular bioenergetics research.

    About Genoscience

    Located in Sarasota, Florida, Genoscience is a leading institutional supplier of high-purity, HPLC-verified synthetic peptides and molecular probes. Dedicated exclusively to supporting advanced in-vitro laboratory analysis and research, Genoscience provides principal investigators with uncompromising analytical transparency, cGMP-compliant sourcing, and secure domestic logistics to ensure optimal experimental reproducibility. For more information, visit Genoscience.net.

    Important Legal & Safety Notice: All compounds discussed are intended for in-vitro research and analytical use only. They are not approved for human or animal consumption. Researchers are solely responsible for ensuring their handling, reconstitution, and storage protocols meet all applicable institutional, ethical, and legal standards.

    Media Contact

    Organization: Genoscience

    Contact Person: Kristelle Dammarell

    Website: https://genoscience.net/

    Email: Send Email

    City: Sarasota

    State: Florida

    Country:United States

    Release id:44387

    The post Genoscience Wins 2026 Global Award for High-Purity Research Peptides appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

    file

  • VestaDAO Introduces Three Innovations to Break DeFi Liquidity Constraints

    Protocol-Owned Markets, Contribution-Based Asset Ownership, Dual-Token Flywheel—VestaDAO Redefines Decentralized Finance
     

    From the “liquidity mining” boom in 2020 to today’s TVL stabilizing above $130 billion, DeFi has expanded rapidly—but it has also exposed deep structural flaws: protocols rely on high rewards to “rent” liquidity, only to collapse when capital exits; governance tokens lack value anchoring and devolve into speculative instruments; ordinary users’ contributions cannot be properly recognized, leaving ecosystems dominated by whales. These problems are now being systematically addressed by a new-generation DeFi 5.0 platform: VestaDAO.

    Protocol-Owned Liquidity: No More “Renting,” Becoming the Market Itself

    Traditional DeFi protocols often pay high native token incentives to attract LPs. Once rewards decline, liquidity quickly disappears, creating fertile ground for “vampire attacks.” VestaDAO adopts a Protocol-Owned Liquidity (POL) mechanism, acquiring and permanently controlling LP assets through bond sales. All inflows are automatically split into treasury reserves and protocol-owned liquidity, and deployed through an AI-powered Stratified Liquidity System (SLS) into key value zones such as price floors, anti-dump ranges, and resistance bands, actively managing price stability.

    This means: VestaDAO no longer “rents” liquidity—it is the market.

    Dual-Token Separation Model: Ending the “Hold vs. Use” Dilemma
    Many DeFi protocols face a trade-off: tokens used for governance are hard to use for payments, and tokens used for transactions struggle to store value. VestaDAO introduces an original dual-token model: VSD + DF5.

    • VSD: An algorithmic non-stable coin backed by treasury assets, used for bonds, staking, ecosystem payments, and governance. Every VSD is supported by an equal or greater Risk-Free Value (RFV) from the treasury. • DF5: A contribution token with a total supply of 1 million and a final circulating supply of only 10,000. It is generated exclusively through invitation actions and the CVA contribution value algorithm. In early stages, it can only be sold (not bought) on the secondary market, with a one-sided sell mechanism and buyback support.

    Together, they form a flywheel: staking VSD generates yield, while consuming DF5 accelerates reward release. As DF5 is continuously burned, its scarcity increases, feeding back into the VSD ecosystem. Users no longer need to choose between “holding for appreciation” and “spending for utility.”

    Contribution Value Ownership: Every Action Becomes an Asset
    VestaDAO upgrades traditional DeFi from a “capital-driven” model to a“capital + contribution dual-driven” system. Any action that contributes to ecosystem growth—inviting new users, long-term staking, social engagement, governance participation—is quantified through the CVA (Contribution Value Algorithm) and mapped into DF5 token rewards, released linearly over 365 days to encourage sustained participation.

    Referral rewards can reach up to 160% of the staking value, distributed across 30 layers; community contribution rewards are settled daily in VSD; NFT membership card holders enjoy multiple layers of premium dividends. Here, every like, invite, and vote you make is converted into tangible assets.

    The Engine of DeFi 5.0 Has Ignited
    VestaDAO is incubated by top-tier institution Spartan Capital, with support from Binance Chain technical teams and resources tied to the London Stock Exchange. The year 2026 is widely seen as the beginning of “system-level application” breakthroughs, and VestaDAO positions itself as both a pioneer and a definer of this new era.

    Following its mainnet launch, VSD staking offers compound yields of up to 3,000% APY, while DF5 contribution incentives are rapidly expanding across global communities. Whether you are an experienced DeFi participant or a newcomer to Web3, VestaDAO offers a fair starting line where “contribution equals reward.”

    Join VestaDAO and help build a decentralized financial world that is free, fair, inclusive, and independent.

    Media Contact

    Organization: Vesta Dao

    Contact Person: Jenny

    Website: https://app.vestadao.finance

    Email: Send Email

    Country:United States

    Release id:44405

    The post VestaDAO Introduces Three Innovations to Break DeFi Liquidity Constraints appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

    file

  • Digital Smart AI GPU Rental Platform Powers Scalable AI Solutions for Modern Enterprises

    As artificial intelligence becomes a central driver of productivity and innovation, businesses are under increasing pressure to adopt AI capabilities quickly and cost-effectively. Digital Smart AI is addressing this demand by offering a scalable AI solutions ecosystem combined with a flexible GPU rental platform, allowing companies to access high-performance computing without the burden of traditional infrastructure investment.

    Unlike conventional AI deployment models that require heavy upfront spending on hardware and maintenance, Digital Smart AI provides on-demand GPU computing resources tailored to real-time business needs. This approach enables organizations to scale their AI operations efficiently, whether they are training machine learning models, running data analytics, or deploying AI-powered applications.

    Scalable AI Solutions for Real-World Business Applications

    Digital Smart AI delivers a range of practical AI tools designed to integrate seamlessly into existing workflows. These include AI-powered content generation systems, image synthesis tools for marketing and design, and predictive analytics solutions that help businesses make data-driven decisions.

    A key advantage of the platform is its accessibility. Both technical and non-technical teams can leverage its tools without needing deep expertise in AI development. This lowers the barrier to entry and accelerates the adoption of AI technologies across industries such as e-commerce, finance, healthcare, and digital media.

    Flexible GPU Rental Platform for Cost Optimization

    At the core of Digital Smart AI’s offering is its GPU rental platform, which provides high-performance computing resources on a pay-as-you-go basis. Businesses no longer need to purchase expensive GPUs or manage complex infrastructure. Instead, they can allocate computing power dynamically based on workload requirements.

    This model not only reduces capital expenditure but also improves operational efficiency. Companies can scale resources up during peak demand—such as large-scale AI model training—and scale down when workloads decrease, ensuring optimal cost control.

    Reliable Infrastructure and Continuous Support

    Digital Smart AI ensures stable and secure computing performance through its managed infrastructure. The platform handles system maintenance, updates, and monitoring, allowing businesses to focus on core operations rather than IT management.

    With increasing demand for large AI models and data-intensive workloads, reliability becomes critical. Digital Smart AI’s architecture is designed to support high-performance tasks such as deep learning training and large-scale data processing, backed by continuous technical support to ensure uninterrupted service.

    Bridging the AI Infrastructure Gap

    The rapid evolution of AI technologies has created a divide between organizations with access to advanced computing resources and those without. Digital Smart AI bridges this gap by offering shared GPU infrastructure that democratizes access to powerful computing capabilities.

    Startups, small businesses, and large enterprises alike can benefit from this model. By removing the need for significant upfront investment, companies can experiment with AI, shorten development cycles, and bring innovative solutions to market faster.

    Driving the Future of AI Adoption

    Digital Smart AI positions itself as a key enabler of digital transformation by combining scalable AI tools with flexible computing resources. Its integrated approach allows businesses to adopt, deploy, and expand AI solutions with greater speed and efficiency.

    As AI continues to reshape industries, platforms like Digital Smart AI will play a critical role in making advanced technologies more accessible, helping organizations unlock new growth opportunities and stay competitive in an increasingly data-driven world.

    Media Contact

    Organization: Digital Smart – AI

    Contact Person: DARRYL JOEL DORFMAN

    Website: https://www.ai-digitalsmart.com/

    Email: Send Email

    Country:United States

    Release id:44413

    The post Digital Smart AI GPU Rental Platform Powers Scalable AI Solutions for Modern Enterprises appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

    file

  • SeaPRwire Enhances PR Links across Asia’s Four Core Hubs

    Hong Kong – April 27, 2026 – (SeaPRwire) – As one of the most economically dynamic regions in the world, the linkage between Asia’s core business hubs is becoming increasingly close. To adapt to this trend and help multinational enterprises achieve highly efficient cross-regional PR synergy, SeaPRwire (https://seaprwire.com) announced today that it has officially completed a comprehensive strategic upgrade of its “one-stop” PR communication links across Japan, South Korea, Hong Kong, and Singapore.

    Japan, South Korea, Hong Kong, and Singapore, as Asia’s four major economic and financial engines, each possess unique media ecosystems and business cultures, yet they are simultaneously the preferred choices for many multinational enterprises setting up Asia-Pacific headquarters. In the past, when enterprises conducted PR placements in these regions, they often had to interface with different local agencies, which not only incurred high communication costs but also made it difficult to guarantee brand tonality consistency. The core of SeaPRwire’s upgrade this time is to break down geographical barriers and integrate top-tier media resources from these four regions in a modular, one-stop manner.

    Through the upgraded full-featured workbench, corporate PR teams only need to use a single background to simultaneously assign and monitor news distribution tasks in these four countries and regions. Based on the communication goals set by the enterprise, the AI system automatically coordinates the distribution rhythm of media across the four regions. Whether releasing strategies in Singapore, synchronizing with capital markets in Hong Kong, or conducting localized product promotions in Japan and South Korea, millisecond-level cross-border synergy and voice resonance can be achieved.

    “Business competition in Asia has long ceased to be a solo fight; it is a contest of regional synergy,” emphasized SeaPRwire’s VP of Product. “By opening up the links across Japan, South Korea, Hong Kong, and Singapore, we aim to provide enterprises with a ‘PR highway network’ covering Asia’s core economic circles. Enterprises can easily leverage the attention of mainstream media across the entirety of Asia as simply as distributing drafts locally.”

    About SeaPRwire

    SeaPRwire is Asia’s leading AI-driven earned media management platform, purpose-built to empower PR and communications professionals. Through its flagship Branding-Insight Program, the platform connects clients to over 80,000 journalists and an influencer matrix reaching 300 million followers. Leveraging advanced AI, SeaPRwire helps users identify media targets, personalize pitches, and measure PR impact across key APAC markets, including Japan, China, Korea, and Southeast Asia.

    Media Contact

    Company: SeaPRwire

    Contact: Media Relations Team

    Email: cs@seaprwire.com

    Website: https://seaprwire.com

  • Reed Haimson: Why the 1031 Exchange Is Still the Smartest Wealth-Building Tool Most Investors Misunderstand

    • How industry expert Reed Haimson explains why strategic real estate deferral continues to outperform short-term thinking in modern investment portfolios

    Nashville, TN, 27th April 2026, ZEX PR WIRE — Most real estate investors focus on what feels immediate: cash flow, appreciation, and the next deal. But some of the most successful wealth builders operate on a completely different timeline. They think in decades, not transactions. At the center of that long-game strategy is the 1031 exchange, a tax-deferral mechanism that allows investors to sell a property and reinvest the proceeds into another “like-kind” property without immediately paying capital gains taxes.

    Industry expert Reed Haimson of Passive Realty Group, a CERTIFIED FINANCIAL PLANNER® and Founder and President, frequently emphasizes that the real advantage is not just tax deferral, but capital preservation across multiple investment cycles. In his view, the biggest mistake investors make is treating real estate exits as endpoints rather than transitions.

    Despite its long-standing presence in the U.S. tax code, the 1031 exchange is still widely misunderstood. Many investors either underuse it, misuse it, or fail to integrate it into a broader wealth-building strategy. The result is a pattern of unnecessary tax exposure and stalled portfolio growth.

    At Passive Realty Group, investor education often starts with a simple question posed by Reed Haimson himself: are you building income, or are you building wealth? The 1031 exchange is one of the clearest bridges between the two. It allows investors to keep their capital fully deployed, rather than losing a significant portion of it to taxation at each sale.

    When used correctly, it becomes less of a tax tactic and more of a compounding engine that quietly accelerates portfolio growth across multiple property cycles.

    How the 1031 Exchange Actually Creates Momentum, Not Just Deferral

    On paper, the 1031 exchange appears simple: sell one investment property, reinvest into another, and defer capital gains taxes. In practice, its real power lies in what it prevents: capital erosion.

    Reed Haimson often describes this as “leakage in the system,” where every taxable sale quietly shrinks an investor’s reinvestment capacity. Without a 1031 exchange, each profitable sale typically triggers a tax event that can significantly reduce reinvestment power. This slows portfolio scaling and limits long-term compounding.

    The 1031 exchange removes that friction. By preserving full equity, investors are able to move into larger or higher-performing assets without restarting from a reduced capital base. Over time, this creates a compounding effect where each transaction builds on the last rather than resetting progress.

    However, Reed Haimson is quick to correct the misconception that it is simply a tax delay. That framing undersells its strategic value. It is about repositioning capital efficiently across market cycles, not just postponing taxes.

    Investors who understand this principle often use exchanges to shift from active management to passive structures, from lower-growth markets to high-appreciation regions, or from single assets into diversified portfolios. The exchange becomes less about the property being sold and more about the next strategic position in a long-term wealth map.

    Common Misunderstandings That Cost Investors Long-Term Growth

    Despite its advantages, the 1031 exchange is frequently misapplied, and those mistakes often stem from oversimplification.

    Reed Haimson points out that one of the most common misconceptions is assuming that any property swap qualifies as a like-kind exchange without careful planning. In reality, IRS rules are strict. The identification window, closing timeline, and use of a qualified intermediary are all non-negotiable. Missing even one step can invalidate the entire tax deferral.

    Another misunderstanding is timing. Investors often rush into exchanges without aligning them to broader portfolio goals. A poorly timed exchange can lock capital into an underperforming asset simply to meet a deadline, which defeats the purpose of strategic reinvestment.

    Emotional decision-making is another major issue. Many investors treat the exchange as a reaction to market pressure rather than a proactive strategy. They sell because management becomes inconvenient or because they believe the market has peaked, not because the asset no longer fits their long-term plan.

    Perhaps the most costly misunderstanding is the failure to integrate estate planning. The 1031 exchange does not eliminate taxes; it defers them. Without proper structuring, deferred tax exposure can carry forward to heirs unless addressed through long-term planning strategies.

    These gaps are not failures of the tool itself but failures of strategy.

    Strategic Application: Turning Exchanges Into Portfolio Architecture

    When applied with intention, the 1031 exchange becomes a cornerstone of portfolio architecture rather than a one-time tax strategy.

    Reed Haimson and Passive Realty Group approach each exchange as a deliberate upgrade in an investor’s financial blueprint. Sophisticated investors use it to continuously refine holdings, moving from management-heavy assets into professionally managed structures, from moderate-growth markets into high-growth corridors, or from scattered properties into consolidated, higher-efficiency assets.

    This is where advisory-led investing becomes essential. The focus shifts from transaction execution to strategic direction. Each exchange is evaluated based on its contribution to long-term financial independence rather than short-term tax savings.

    Market selection plays a key role. Investors are encouraged to evaluate macroeconomic indicators such as job growth, population migration, infrastructure development, and rental demand stability rather than relying solely on local familiarity.

    Advanced strategies may also pair 1031 exchanges with value-add improvements or repositioning strategies post-exchange to enhance income performance in the new asset.

    The result is a portfolio that evolves intentionally over time, more structured, more efficient, and increasingly aligned with long-term goals.

    Why the 1031 Exchange Still Matters in a Changing Economy

    In a financial environment shaped by inflation, interest rate shifts, and ongoing tax policy discussions, some investors question whether the 1031 exchange will remain relevant. Despite periodic scrutiny, Reed Haimson notes that it continues to endure because it serves a fundamental economic function: encouraging reinvestment rather than stagnation.

    From a macro perspective, it maintains liquidity in real estate markets. From an investor perspective, it enables continuous asset upgrading without frictional tax loss. That combination remains rare in taxation policy.

    Its effectiveness, however, depends on investor sophistication. As markets become more competitive, the advantage is no longer simply knowing the 1031 exchange exists, but knowing how to integrate it into a long-term wealth strategy.

    Reed Haimson frames this distinction as the difference between participation and positioning. Those who treat it as a technical tax tool achieve limited outcomes. Those who treat it as a portfolio-building mechanism unlock compounding benefits over time.

    Ultimately, the 1031 exchange is not about avoiding taxes in the short term. It is about controlling the trajectory of wealth over decades. In that context, it remains one of the most powerful yet underutilized tools in real estate investing today.

    Contact Information
    Reed Haimson
    Founder and President, Passive Realty Group
    Email: IR@passiverealtygroup.com
    LinkedIn: Reed Haimson
    Website: www.passiverealtygroup.com

  • Vincere Trading Relaunches to Deliver Hedge Fund-Grade Algorithms to Individual Investors Using Cash Accounts

    • Audited multi-year performance and institutional futures systems aim to redefine retail access to algorithmic trading strategies

    Illinois, USA, 27th April 2026, ZEX PR WIRE — Vincere Trading, a fintech company founded to bridge the gap between institutional investment systems and retail accessibility, has officially announced its relaunch. Originally launched last year, the company is entering a new phase of growth with a renewed mission focused on enabling individual investors to access hedge fund-grade algorithmic trading strategies using cash account capital.

    The relaunch reflects a broader evolution in how the company positions itself within the growing landscape of automated trading. As financial markets continue to shift toward data-driven execution and systematic decision-making, Vincere Trading is emphasizing infrastructure that supports scalability, discipline, and long-term consistency for retail participants.

    Co-founded by partner Alex Cecola, the firm was built on the belief that institutional trading systems should not remain exclusive to hedge funds and large financial institutions. Instead, these strategies can be re-engineered into structured, accessible frameworks that allow individual traders to participate in similar models of execution and risk management.

    Relaunch and Strategic Vision

    The relaunch of Vincere Trading marks a deliberate expansion of both its technology and its long-term mission. While the company initially launched last year as a fintech startup, its renewed direction focuses on scaling access to automated trading systems designed for real-world application across retail and prop firm environments.

    At its core, the company’s vision is centered on democratizing access to institutional-style trading methodologies. Rather than relying on discretionary trading or simplified retail tools, Vincere Trading focuses on building structured algorithmic systems that operate with predefined logic and disciplined execution frameworks.

    This strategic shift is driven by the increasing demand for automation in financial markets. As traders seek more efficient and less emotionally driven approaches, Vincere Trading is positioning itself as a bridge between professional quantitative finance and individual participation.

    Institutional-Grade Algorithmic Framework

    Vincere Trading’s platform is built around a diversified suite of futures trading algorithms developed using institutional design principles. These systems are structured, rules-based, and engineered to perform across a wide range of market conditions, including both high volatility and low momentum environments.

    The firm’s approach is rooted in diversification at the strategy level. Rather than relying on a single model, the system operates as a portfolio of uncorrelated algorithms, each designed with different entry logic and behavioral responses to market movement. This structure is intended to reduce concentration risk while improving long-term stability.

    Risk management is a foundational component of the framework. Each algorithm operates within predefined parameters that govern exposure, drawdown control, and capital allocation. The goal is not only performance generation but also preservation of capital across varying market cycles.

    By incorporating principles commonly used in hedge fund environments, Vincere Trading seeks to replicate institutional rigor in a format that is accessible to non-institutional participants.

    Audited Performance and Long-Term Consistency

    A key component of the relaunch announcement is the audited performance history of Vincere Trading’s algorithmic suite. Over the past six years, the company’s strategies have demonstrated nearly 50 percent average annual growth, based on internal tracking and audit review of system performance.

    This track record reflects a long-term development process that prioritizes consistency over short-term optimization. The algorithms have undergone continuous refinement, including adjustments to volatility conditions, execution efficiency, and adaptive market behavior.

    Rather than relying on isolated performance periods, Vincere Trading emphasizes sustained multi-cycle results. The company highlights that its systems have been designed to function across changing macro environments, ensuring that strategies are not dependent on a single market regime.

    The audit serves as a validation of both methodology and execution discipline. It reinforces the company’s commitment to data-driven development and systematic validation rather than discretionary assumptions.

    Expanding Access Through Cash Accounts and Prop Firm Integration

    One of the defining elements of Vincere Trading’s model is its focus on accessibility through cash-based trading accounts and prop firm structures. This dual-access approach allows traders to engage with institutional-grade systems without requiring large upfront capital commitments.

    Through prop firm integration, users can access significantly larger pools of capital while maintaining limited personal financial exposure. This structure enables traders to scale positions and potential returns while operating within controlled risk environments.

    The company’s system is designed to function efficiently across multiple accounts, allowing for capital scaling and portfolio diversification. By automating execution and removing manual decision-making, Vincere Trading aims to create a largely hands-free trading experience.

    The emphasis on accessibility is central to the company’s broader mission. By lowering structural barriers, Vincere Trading is attempting to expand participation in systematic trading while maintaining the discipline and rigor associated with institutional frameworks.

    As the company continues its relaunch phase, it plans to further develop its algorithmic suite, enhance execution infrastructure, and expand educational resources to support user understanding of quantitative trading principles.

    Vincere Trading’s long-term objective is to establish a scalable ecosystem where individual investors can operate using systems traditionally reserved for hedge funds. Through automation, diversification, and institutional methodology, the company is positioning itself as a key participant in the evolution of modern algorithmic trading.

    About Vincere Trading

    Vincere Trading is a fintech firm focused on transforming access to advanced trading strategies by bringing institutional-grade algorithmic systems to individual investors. Co-founded by partner Alex Cecola, the company was established to remove traditional barriers that have long separated retail traders from the tools and performance frameworks used by hedge funds. Following its launch last year, Vincere Trading is entering a new phase with a relaunch aimed at expanding accessibility, scalability, and automation for a broader base of traders.

    The company’s core offering centers on a diversified portfolio of futures trading algorithms built on disciplined, rules-based methodologies. These systems are designed to operate across varying market conditions, combining risk management with adaptability. Over a six-year period, Vincere Trading’s suite of algorithms has been audited and achieved nearly 50% average annual growth, reflecting a consistent and performance-driven development process.

    A key focus for Vincere Trading is the prop firm trading space, where traders can access substantial capital without deploying large personal funds. Through its structured approach, the firm provides tools that support traders in navigating strict evaluation criteria while maintaining a systematic, hands-off trading experience. Its strategies are designed to scale efficiently across multiple accounts, allowing users to grow their trading footprint with minimal manual input.

    By integrating quantitative expertise, modern technology, and a commitment to accessibility, Vincere Trading continues to position itself as a forward-looking player in algorithmic trading, offering solutions built for both performance and long-term sustainability.

    Contact Information

    Vincere Trading
    Website: https://www.vinceretrading.com
    About: https://www.vinceretrading.com/#about-us
    Upcoming Platform: https://vincereportfolios.com/ 

    For media inquiries, partnership opportunities, or to learn more about Vincere Trading’s algorithmic trading solutions, please visit the official website or use the contact options available on the platform.

  • Valyra Exchange: A Comprehensive Platform Powering the Future of Digital Finance

    United States, 27th Apr 2026 – As the global financial system shifts toward decentralization, platforms that can bridge traditional finance and blockchain technology are gaining increasing attention. Valyra Exchange is one such platform, positioning itself as a full-stack digital asset ecosystem that goes beyond simple trading and moves toward a more integrated financial infrastructure.

    Unlike conventional crypto exchanges that focus primarily on buying and selling assets, Valyra Exchange is structured to support a wide range of financial activities within a single environment. Users can access spot trading, derivatives markets, fiat gateways, and decentralized finance services without needing to switch between platforms. This unified design reduces friction and allows for more efficient asset management.

    A central theme behind Valyra Exchange is accessibility. Many existing platforms remain complex, fragmented, or overly dependent on centralized control. Valyra addresses this by simplifying the user experience while still maintaining advanced functionality for professional traders. The platform’s interface, combined with its infrastructure, is designed to support both entry-level users and experienced market participants.

    Technology is a key differentiator for Valyra Exchange. The platform utilizes a distributed system architecture capable of supporting high-frequency trading environments. Its matching engine is optimized for speed and stability, enabling fast execution even during periods of high market volatility. At the same time, the system is built with scalability in mind, ensuring it can handle long-term growth in users and transaction volume.

    Security remains a priority throughout the platform’s design. Valyra Exchange employs a layered security framework that includes cold storage, multi-signature wallets, and encrypted data handling. These measures are complemented by continuous monitoring systems that detect abnormal activity in real time. The platform also follows international compliance standards, implementing identity verification and anti-money laundering protocols to ensure regulatory alignment.

    One of the more strategic aspects of Valyra Exchange is its approach to decentralized trust. By leveraging blockchain technology, the platform minimizes reliance on centralized authorities. Transactions are transparent, verifiable, and resistant to tampering. Smart contracts play a critical role in automating processes such as settlement and clearing, improving both efficiency and reliability.

    Valyra Exchange also recognizes the importance of global capital mobility. Traditional cross-border transactions are often slow and expensive due to intermediary layers. By using tokenized assets and blockchain-based transfers, Valyra enables faster and more cost-effective international transactions. This capability is particularly relevant in a digital economy where financial interactions are no longer limited by geography.

    Beyond trading, the platform is actively building a broader ecosystem. Its roadmap includes decentralized lending services, digital asset banking functions, and integrations with real-world industries such as supply chain finance and e-commerce. This expansion reflects a long-term strategy to evolve into a decentralized financial hub rather than remain a standalone exchange.

    Another critical component of Valyra Exchange is its focus on tokenization. By converting real-world assets into blockchain-based tokens, the platform enables new forms of liquidity and ownership transfer. This opens the door to more efficient markets, where assets can be traded, verified, and managed with greater transparency.

    The long-term vision of Valyra Exchange is to create a financial system that is open, efficient, and globally accessible. Its mission is rooted in reducing trust dependency, increasing transparency, and providing users with greater control over their financial activities. In doing so, it aligns closely with the broader goals of the blockchain industry.

    In a rapidly evolving market, platforms that combine strong technical infrastructure with a clear strategic vision tend to stand out. Valyra Exchange is positioning itself as one of these platforms, aiming to play a meaningful role in shaping the next phase of digital finance.

    Media Contact

    Organization: Valyra Exchange

    Contact Person: Alice

    Website: https://www.valyra.us/

    Email: Send Email

    Country:United States

    Release id:44406

    Disclaimer: This content is provided for informational purposes only and does not constitute financial, investment, legal, or trading advice. Digital asset platforms and blockchain technologies involve risk, and readers should conduct independent research and consult qualified professionals before making any decisions.

    The post Valyra Exchange: A Comprehensive Platform Powering the Future of Digital Finance appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

    file